Gao, Y., Li, X., Zhang, X., Wang, X., Cai, Q., Bai, B., Ping, L., Hong, J., Huang, H. (2025). A multicenter, single-arm study of camrelizumab combined with rituximab followed by R-CHOP as first-line treatment for young patients with primary extranodal diffuse large B-cell lymphoma: The credit trial. Blood. https://doi.org/10.1182/blood-2025-5517